LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: RSK3 switches cell fate: from stress-induced senescence to malignant progression.

    Huna, Anda / Flaman, Jean-Michel / Lodillinsky, Catalina / Zhu, Kexin / Makulyte, Gabriela / Pakulska, Victoria / Coute, Yohann / Ruisseaux, Clémence / Saintigny, Pierre / Hernandez-Vargas, Hector / Defossez, Pierre-Antoine / Boissan, Mathieu / Martin, Nadine / Bernard, David

    Journal of experimental & clinical cancer research : CR

    2023  Volume 42, Issue 1, Page(s) 318

    Abstract: Background: TGFβ induces several cell phenotypes including senescence, a stable cell cycle arrest accompanied by a secretory program, and epithelial-mesenchymal transition (EMT) in normal epithelial cells. During carcinogenesis cells lose the ability to ...

    Abstract Background: TGFβ induces several cell phenotypes including senescence, a stable cell cycle arrest accompanied by a secretory program, and epithelial-mesenchymal transition (EMT) in normal epithelial cells. During carcinogenesis cells lose the ability to undergo senescence in response to TGFβ but they maintain an EMT, which can contribute to tumor progression. Our aim was to identify mechanisms promoting TGFβ-induced senescence escape.
    Methods: In vitro experiments were performed with primary human mammary epithelial cells (HMEC) immortalized by hTert. For kinase library screen and modulation of gene expression retroviral transduction was used. To characterize gene expression, RNA microarray with GSEA analysis and RT-qPCR were used. For protein level and localization, Western blot and immunofluorescence were performed. For senescence characterization crystal violet assay, Senescence Associated-β-Galactosidase activity, EdU staining were conducted. To determine RSK3 partners FLAG-baited immunoprecipitation and mass spectrometry-based proteomic analyses were performed. Proteosome activity and proteasome enrichment assays were performed. To validate the role of RSK3 in human breast cancer, analysis of METABRIC database was performed. Murine intraductal xenografts using MCF10DCIS.com cells were carried out, with histological and immunofluorescence analysis of mouse tissue sections.
    Results: A screen with active kinases in HMECs upon TGFβ treatment identified that the serine threonine kinase RSK3, or RPS6KA2, a kinase mainly known to regulate cancer cell death including in breast cancer, reverted TGFβ-induced senescence. Interestingly, RSK3 expression decreased in response to TGFβ in a SMAD3-dependent manner, and its constitutive expression rescued SMAD3-induced senescence, indicating that a decrease in RSK3 itself contributes to TGFβ-induced senescence. Using transcriptomic analyses and affinity purification coupled to mass spectrometry-based proteomics, we unveiled that RSK3 regulates senescence by inhibiting the NF-κΒ pathway through the decrease in proteasome-mediated IκBα degradation. Strikingly, senescent TGFβ-treated HMECs display features of epithelial to mesenchymal transition (EMT) and during RSK3-induced senescence escaped HMECs conserve EMT features. Importantly, RSK3 expression is correlated with EMT and invasion, and inversely correlated with senescence and NF-κΒ in human claudin-low breast tumors and its expression enhances the formation of breast invasive tumors in the mouse mammary gland.
    Conclusions: We conclude that RSK3 switches cell fate from senescence to malignancy in response to TGFβ signaling.
    MeSH term(s) Animals ; Female ; Humans ; Mice ; Breast Neoplasms/pathology ; Epithelial-Mesenchymal Transition/genetics ; Mammary Neoplasms, Animal ; Proteasome Endopeptidase Complex/metabolism ; Proteomics ; Signal Transduction ; Transforming Growth Factor beta/metabolism
    Chemical Substances Proteasome Endopeptidase Complex (EC 3.4.25.1) ; Transforming Growth Factor beta ; ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC 2.7.11.1)
    Language English
    Publishing date 2023-11-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 803138-1
    ISSN 1756-9966 ; 0392-9078
    ISSN (online) 1756-9966
    ISSN 0392-9078
    DOI 10.1186/s13046-023-02909-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Benidipine calcium channel blocker promotes the death of cigarette smoke-induced senescent cells and improves lung emphysema.

    Palazzo, Alberta / Makulyte, Gabriela / Goerhig, Delphine / Médard, Jean-Jacques / Gros, Vincent / Trottein, François / Adnot, Serge / Vindrieux, David / Flaman, Jean-Michel / Bernard, David

    Aging

    2023  Volume 15, Issue 23, Page(s) 13581–13592

    Abstract: Smoking is the main risk factor for many lung diseases including chronic obstructive pulmonary disease. Cigarette smoke (CS) contains carcinogenic and reactive oxygen species that favor DNA mutations and perturb the homeostasis and environment of cells. ... ...

    Abstract Smoking is the main risk factor for many lung diseases including chronic obstructive pulmonary disease. Cigarette smoke (CS) contains carcinogenic and reactive oxygen species that favor DNA mutations and perturb the homeostasis and environment of cells. CS induces lung cell senescence resulting in a stable proliferation arrest and a senescence-associated secretory phenotype. It was recently reported that senescent cell accumulation promotes several lung diseases. In this study, we performed a chemical screen, using an FDA-approved drug library, to identify compounds selectively promoting the death of CS-induced senescent lung cells. Aside from the well-known senolytic, ABT-263, we identified other potentially new senescence-eliminating compounds, including a new class of molecules, the dihydropyridine family of calcium voltage-gated channel (CaV) blockers. Among these blockers, Benidipine, decreased senescent lung cells and ameliorates lung emphysema in a mouse model. The dihydropyridine family of CaV blockers thus constitutes a new class of senolytics that could improve lung diseases. Hence, our work paves the way for further studies on the senolytic activity of CaV blockers in different senescence contexts and age-related diseases.
    MeSH term(s) Mice ; Animals ; Calcium Channel Blockers/pharmacology ; Calcium Channel Blockers/therapeutic use ; Cigarette Smoking/adverse effects ; Pulmonary Emphysema/genetics ; Lung/metabolism ; Dihydropyridines/pharmacology ; Dihydropyridines/therapeutic use ; Dihydropyridines/metabolism ; Emphysema/metabolism ; Cellular Senescence
    Chemical Substances Calcium Channel Blockers ; benidipine (4G9T91JS7E) ; Dihydropyridines
    Language English
    Publishing date 2023-12-12
    Publishing country United States
    Document type Journal Article
    ISSN 1945-4589
    ISSN (online) 1945-4589
    DOI 10.18632/aging.205259
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top